Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 3 1

Status

Completed 6Unknown 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 2

Conditions

Prostatic Neoplasms 4Carcinoma, Hepatocellular 2

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Interventional × fluorocholine × Clear all
NCT04391348 2023-11-18

PET-HCC01

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
230 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02397408 2020-11-19

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

University of California, San Francisco

Phase 2 Completed
18 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT04340765 2020-04-13

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

Buddhist Tzu Chi General Hospital

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT01395030 2018-09-26

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Queen's Medical Center

Phase 2 Completed
64 enrolled 13 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02840552 2018-08-09

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

Sir Mortimer B. Davis - Jewish General Hospital

Phase 3 Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT01993160 2017-01-13

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

University Health Network, Toronto

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡